DNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 ?M for AMPA and kainate receptors, respectively versus IC50 = 40 ?M for NMDA receptors).{23070,23071,23072} This compound has been used to specifically target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors. DNQX does not stimulate a robust long-term potentiation in the hippocampus.{23069}
Productname
DNQX
14583-25
By filling out this form, you are placing an order by e-mail. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.
Productname
DNQX
14583-25
By filling out this form, you request a sample. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.
Are you looking for specific products, alternatives or documentation?